Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • OnUrMark
    Member
    • Jan 2011
    • 24

    #1

    TruSeq RNA initial concentration and Ampure beads

    Greetings!

    I am getting ready to use the TruSeq RNA kit for the first time. I noticed the concentration of Ampure beads to sample decreases as you progress through the steps to prepare an RNASeq sample. I assume that as the bead concentration to DNA decreases, the maximum length of fragment washed away will increase.

    Ex: 1.8:1 bead: DNA removes anything less than 100bp. Then perhaps 1:1 bead: DNA would remove anything less than 200bp.

    1) Is this a correct assumption?
    2) Has anyone found that varying the initial RNA concentration affects the maximum length of fragment washed away and results in a different final fragment length?

    Thanks in advance for your help and sharing your knowledge on this preparation technique.
  • RNAseqer
    Member
    • Sep 2010
    • 22

    #2
    According to what I've read anything greater than a 1x ratio will recover everything <~100. Its only when you go less than 1x do you start being able to size select, ie. .5X or .75X. I'd be interested in the experience of others too.

    Comment

    • OnUrMark
      Member
      • Jan 2011
      • 24

      #3
      Hi RNAseqer,

      I am guessing you mean a 1x ratio will recover everything >~100bp. I am concerned if this is true because adapter dimers must be removed, and they are ~120bp.

      Thanks,

      OnUrMark

      Comment

      • ECO
        --Site Admin--
        • Oct 2007
        • 1360

        #4
        In general (not speaking specifically about the TruSeq kit, and its adapters)...but 1x will definitely recover a large fraction of 120bp dsDNA. Even very aggressive cuts (0.5x) will leave a lot of 100bp fragments (by gel staining and PCR).

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 08-13-2026, 12:22 PM
        0 responses
        25 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 08-11-2026, 10:35 AM
        0 responses
        21 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 08-06-2026, 07:41 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 08-03-2026, 10:13 AM
        0 responses
        51 views
        0 reactions
        Last Post SEQadmin2  
        Working...